Glu9.0

Glucosamine

Glucosamine Sulfate

Popular joint health supplement that may help maintain cartilage and reduce osteoarthritis symptoms over time.

bodyjoint healthcartilagearthritismobility
Last reviewed: January 1, 2025
9.0/10
40+ studies
Evidence
high
Safety
1500mg glucosamine sulfate
Dose
8-24 weeks
Time to Effect
Glucosamine sulfate (most studied)
Best Form

Glucosamine is a natural compound found in cartilage. Supplementation, particularly glucosamine sulfate, is widely used for joint health and osteoarthritis. Research shows modest benefits for reducing joint pain and slowing cartilage breakdown with long-term use. Effects take weeks to months to appear and are most consistent with the sulfate form.

Mechanisms of Action

ðŸ§ą
Cartilage Building Block

Provides raw material for cartilage synthesis

ðŸ”Ĩ
Anti-Inflammatory

May reduce joint inflammation

Recommended Dose

1500mg glucosamine sulfate

1200mg2000mg

Optimal Timing

  • With food
  • Once daily or split into 3 doses

Take with food

Best Form

Glucosamine sulfate (most studied)

Alternatives: Glucosamine HCl, Glucosamine sulfate 2KCl

Glucosamine sulfate has the most positive research. HCl form has less evidence. Often combined with chondroitin.

Duration

Minimum: 8 weeks

Optimal: 24 weeks

Cycling: Not required

Note: Can be taken as single dose or divided. Taking with food may reduce GI upset. Consistent daily use is important.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

âœĻ
Reduced Joint Pain

Modest reduction in osteoarthritis pain

4-12 weeks
55% of users notice thispositive
ðŸšķ
Improved Function

Better joint mobility and function

8-12 weeks
50% of users notice thispositive
ðŸ›Ąïļ
Cartilage Preservation

May slow cartilage breakdown over time

6-12 months
45% of users notice thispositive
High SafetyMax safe dose: Up to 2000mg/day shown safe
ðŸ”ī
Pregnant/nursing

Insufficient data; avoid supplementation

ðŸŸĄ
Diabetics

Monitor blood sugar; effects may vary

ðŸŸĄ
Shellfish allergy

Use synthetic or vegetarian glucosamine

Who Should NOT Take This

  • Shellfish allergy (if shellfish-derived)
  • Bleeding disorders

Drug Interactions

Warfarinmoderate

May increase INR and bleeding risk

Diabetes medicationsmild

May affect blood sugar in diabetics (inconsistent evidence)

Possible Side Effects

GI upsetuncommon

Tip: Take with food

Headacherare

Tip: May resolve with continued use

Allergic reaction (shellfish source)uncommon

Tip: Use vegetarian/synthetic source

Warnings

  • Effects take weeks to months to appear
  • Results vary — some people don't respond
  • Shellfish-derived forms may cause reactions in allergic individuals

Top studies from 40+ peer-reviewed papers

meta-analysisn=4962
DOI

Singh JA et al. â€Ē The Cochrane database of systematic reviews (2015)

“A review of randomized trials of mostly low quality reveals that chondroitin (alone or in combination with glucosamine) was better than placebo in improving pain in participants with osteoarthritis in short-term studies.”
Key Findings:
  • Loss of minimum joint space width in the chondroitin group was statistically significantly less than in the placebo group, with a relative risk difference of 4.7% less (95% CI 1.6% to 7.8% less; n = 2 trials) (level of evidence, high; risk of bias, low).
  • Chondroitin was associated with statistically significantly lower odds of serious adverse events compared with placebo with Peto odds ratio of 0.40 (95% CI 0.19 to 0.82; n = 6 trials) (level of evidence, moderate).
  • Chondroitin did not result in statistically significant numbers of adverse events or withdrawals due to adverse events compared with placebo or another drug.
  • Differences in Lequesne's index statistically significantly favoured chondroitin as compared with placebo, with an absolute risk difference of 8% lower (95% CI, 12% to 4% lower; T(2) = 0.12; n = 10 trials) (level of evidence, moderate).
systematic-reviewn=146
DOI

Baden KER et al. â€Ē Nutrients (2025)

“Overall, the evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.”
Key Findings:
  • Of the 2013 articles screened, 146 studies were included in our review, with nearly 60% being randomized controlled trials and most conducted in Europe, Asia, or the U.S.
  • Most studies focused on osteoarthritis and joint pain, with over 90% of efficacy studies reporting positive outcomes and most safety studies indicating minimal or no adverse effects.
  • Overall, the evidence suggests that glucosamine and chondroitin are generally effective and well-tolerated, particularly for managing osteoarthritis and joint pain.
  • Consistent dosing strategies and favorable safety profiles across a diverse range of studies support their continued use in clinical practice, but further research is needed related to other disease states.
meta-analysisn=1067
DOI

Meng Z et al. â€Ē Archives of orthopaedic and trauma surgery (2023)

“Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.”
Key Findings:
  • Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.
  • It is worthwhile to popularize and apply the combination in KOA treatment considering the point of effect, tolerability and economic costs.
  • Additionally, regarding the limited number of studies and uneven trial quality, more high-quality trials are required to investigate the accurate clinical advantages of the combination.
meta-analysisn=10
DOI

Iwamoto Y et al. â€Ē Nagoya journal of medical science (2023)

“We hope that more high-quality randomized controlled exercise intervention trials aimed at improving locomotive syndrome, which is a musculoskeletal dysfunction, will be carried out in the future.”
Key Findings:
  • Several individual papers showed that the intervention group significantly improved the outcome measure for the diagnosis of locomotive syndrome compared with the control group.
  • Only oral glucosamine intake provided sufficient information to conduct a meta-analysis, but the results were not statistically significant.
  • This systematic review and meta-analysis did not provide strong evidence for specific interventions in improving locomotive syndrome, although individual randomized controlled trials have shown that oral intake of glucosamine, electrical stimulation, and exercise could improve locomotive syndrome.
systematic-review
DOI

Derwich M et al. â€Ē International journal of molecular sciences (2023)

“Further long-term, randomized, double-blind studies, with a unified methodology, ought to be performed to draw the general recommendations for the use of oral glucosamine in the treatment of TMJ OA.”
Key Findings:
  • Administration of oral glucosamine for a longer period of time, i.e., 3 months, led to a significant reduction in TMJ pain and a significant increase in maximum mouth opening.
  • The most important aspect affecting the clinical efficacy of oral glucosamine in the treatment of TMJ OA was the total administration time.
  • It also resulted in long-term anti-inflammatory effects within the TMJs.
  • Further long-term, randomized, double-blind studies, with a unified methodology, ought to be performed to draw the general recommendations for the use of oral glucosamine in the treatment of TMJ OA.
40
Total Studies
9.0/10
Avg Quality
10-466,039
Sample Size Range
2001-2025
Research Span

Study Type Distribution

Meta-Analysis
18
RCT
12
Systematic Review
9
Cohort
1

Goals This Supplement Supports

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.